Public Company News
LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company and Formation of Special Committee
BEIJING, Aug. 28, 2025 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious d...
2025-08-28 20:00
3767
Xuan Wu Cloud Announces 2025 Interim Financial Results
The Group continues to focus on AI+SaaS business, with gross profit margin increasing year-over-year * In the first half of 2025, Xuan Wu Cloud achieved total revenue of RMB 410.9 million, and gross profit margin reached 18.2%, up 2.6 percentage points year-over-year * The Group served a cum...
2025-08-28 18:29
2107
Cheche Announces Roadmap Featuring New Global Digital Initiatives Across Asia-Pacific, Europe, and Latin America
BEIJING, Aug. 28, 2025 /PRNewswire/ -- Cheche Group Inc.
2025-08-28 18:00
3978
WuXi Biologics' Near-Term and Net-Zero Targets Approved by SBTi
* Committed to net-zero across the value chain by 2050 * Aligned with 1.5°C mitigation pathways, the most ambitious SBTi designation * Leader in Green CRDMO to drive innovation for a healthier future SHANGHAI, Aug. 28, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract ...
2025-08-28 17:00
2924
FIRST CLINICAL EVIDENCE PUBLISHED ON AROA's ENIVO™ SYSTEM FOR SURGICAL DEAD SPACE MANAGEMENT.
AUCKLAND, New Zealand, Aug. 27, 2025 /PRNewswire/ -- AROA is pleased to announce the findings of the first in human study involving its new ENIVO platform technology. The study is the subject of a peer-reviewed publication entitledProspective, First-in-Human Clinical Evaluation of a Novel Tissue ...
2025-08-28 12:29
2365
Ascletis Announces Favorable and Differentiated Pharmacokinetic Profile of ASC30 Oral Once-Daily Tablet in Its U.S. Phase Ib Multiple Ascending Dose Study
- ASC30 oral once-daily tablet demonstrated approximately 2.3-fold to 3.3-fold greater drug exposure than orforglipron in a cross-trial comparison. - Higher drug exposure and favorable tolerability profile positions ASC30 oral once-daily tablet favorably compared to orforglipron...
2025-08-28 07:45
1429
SK hynix Starts Supplying Mobile DRAM with Highly Efficient Heat Dissipation
* Company first in industry to develop High-K EMC material, improves thermal conductivity by 3.5 times, thermal resistance by 47% * Customers expect achievement to help address heat issue generated from on-device AI * SK hynix to lead next-generation DRAM for mobile device through technolog...
2025-08-28 07:30
1666
Trip.com Group Limited Reports Unaudited Second Quarter and First Half of 2025 Financial Results
SINGAPORE, Aug. 27, 2025 /PRNewswire/ -- Trip.com Group Limited (Nasdaq: TCOM; HKEX: 9961) ("Trip.com Group" or the "Company"), a leading global one-stop travel service provider of accommodation reservation, transportation ticketing, packaged tours, and corporate travel management, today announce...
2025-08-28 06:00
4541
Fangzhou Posts Strong 1H Revenue and Profit as Physician Network and User Base Expand
HONG KONG, Aug. 27, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in AI-driven Internet healthcare solutions, reported a profitable first half of 2025, supported by an expanding user base, higher operating efficiency, and accelerated deployment of AI across...
2025-08-27 23:09
2535
Daesang Group Showcases Global Talent at 5th University Student Smartphone Film Festival
- Bali, Indonesia provided the backdrop for a 15-day cultural collaboration, bringing together 48 university students from 17 countries to create food-themed films - Premiere on the 24th at Asia's largest club drew an international crowd - Daesang K-Food Week provided 7,000 visitors with K-Food ...
2025-08-27 22:40
2405
Harbour BioMed Reports 2025 Interim Results
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Aug. 27, 2025 /PRNewswire/ -- Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, today announced its i...
2025-08-27 22:40
2411
XtalPi Holdings Announces 2025 Interim Results
SHENZHEN, China, Aug. 27, 2025 /PRNewswire/ -- Key Highlights from the Financial Report: * Revenue surged 404% year over year to RMB 517 million in the first half of 2025. * Adjusted net profit reached RMB 141 million, marking the company's first-ever half-year profitability. * XtalPi wa...
2025-08-27 22:23
3135
Namibox Set to Launch World's First AI-Powered Learning Glasses
SHANGHAI, Aug. 27, 2025 /PRNewswire/ -- Jinxin Technology Holding Company (the "Company") (Nasdaq: NAMI), recently announced a deep collaboration with MICROLUMIN to co-develop the world's first AI-powered learning glasses. By integrating artificial intelligence with wearable technology, the produ...
2025-08-27 21:30
2177
FTFT Announces Special Meeting of Shareholders
NEW YORK, Aug. 27, 2025 /PRNewswire/ -- Future FinTech Group Inc. (NASDAQ: FTFT), (hereinafter referred to as "Future FinTech", "FTFT" or the "Company"), a comprehensive financial and digital technology service provider, announced today that its special meeting of shareholders will take place on...
2025-08-27 20:30
3668
NaaS Technology Inc. Releases 2024 ESG Report, Highlighting Strong Green Transition Initiatives
BEIJING, Aug. 27, 2025 /PRNewswire/ -- NaaS Technology Inc. (Nasdaq: NAAS) ("NaaS" or the "Company"), the first U.S.-listed EV charging service company in China, today announced the release of its 2024 Environmental, Social and Governance (ESG) Report (the "Report"). The Report underscores the Com...
2025-08-27 20:00
2672
Hyundai Mobis Unveils Future Growth Strategy at CEO Investor Day
* Held 2025 CEO Investor Day on 27th presenting its future growth strategy based on its "New Vision" of leading the mobility paradigm. * Emphasized its strategy to lead the market with leading technologies such as windshield displays, SDV solutions, and BSA, which completely blocks heat trans...
2025-08-27 20:00
1695
Actinogen trial using intended commercial Xanamem tablet formulation confirms target exposures in fed and fasted states
Phase 2b/3 Alzheimer's trial enrolment passes 50% - twenty US trial sites continuing to recruit participants SYDNEY, Aug. 27, 2025 /PRNewswire/ -- Actinogen Medical Limited (ASX: ACW) announces that a recent trial designed to confirm therapeutic blood levels of the intended commercial tablet for...
2025-08-27 20:00
1596
Innovent Announces 2025 Interim Results and Business Updates
* Robust revenue growth and substantial profit improvement * Continued exceptional executions under a clear roadmap of dual-driven growth and global innovation SAN FRANCISCO and SUZHOU, China, Aug. 27, 2025 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class bioph...
2025-08-27 18:08
3225
Keymed Biosciences (02162.HK) Reports Strong Interim 2025 Results with Accelerated Commercialization and Robust R&D Momentum
CHENGDU, China, Aug. 27, 2025 /PRNewswire/ -- Keymed Biosciences Inc. ("Keymed", 02162.HK) announced impressive interim results for 2025, marked by accelerated commercialization and R&D progress. Financially, the company achieved record revenue, driven by the strong performance of its core produ...
2025-08-27 14:02
1260
Winning the 2025 Paris DNA Design Award, AIMA's Santa Monica Electric Bike Empowers E-bike Upgrade
PARIS, Aug. 26, 2025 /PRNewswire/ -- Recently, the 2025 Paris DNA Design Awards
announced its winners list. The Santa Monica electric bike, an E-bike model
from AIMA TECHNOLOGY GROUP CO.,LTD., a leading electric two-wheeler company,
was honored with an Honorable Mention.
2025-08-27 11:41
1533
Week's Top Stories
Most Reposted
MTR Lab and ZGC Science City Ltd Establish Ecosystem Partnership
[Picked up by 310 media titles]
2026-03-18 12:00
Nature's Capital: Why Asia's Governments Are Turning to Nature-Based Solutions
[Picked up by 301 media titles]
2026-03-17 08:00The Mastercard Collection: Savor the Extraordinary with Mastercard's Asia Gourmet Circle Program
[Picked up by 296 media titles]
2026-03-12 09:00Beijing InfoComm China 2026 Conference Lineup Presents Future of AI in Tech Aligning with the Nation's Next Strategic Five-Year Plan
[Picked up by 294 media titles]
2026-03-18 08:00
Agoda and Gangwon State Join Hands to Elevate Gangwon into a Premier Global Travel Destination
[Picked up by 293 media titles]
2026-03-17 11:29
Most Read
HTCO Launches U.S. Strategic Initiative Led by Chairman Christopher Nixon Cox, Establishes Independent Governance Committee for U.S. Operations
2026-03-13 21:30
7319
Insilico Medicine to Announce 2025 Financial Results on March 30, 2026
2026-03-13 21:59
6843